Qube Research & Technologies LTD Jazz Pharmaceuticals PLC Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 56,244 shares of JAZZ stock, worth $7.93 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
56,244
Previous 123,222
54.36%
Holding current value
$7.93 Million
Previous $13.1 Million
43.32%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding JAZZ
# of Institutions
568Shares Held
61.4MCall Options Held
883KPut Options Held
175K-
Black Rock Inc. New York, NY6.15MShares$867 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.91MShares$833 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.84MShares$400 Million0.08% of portfolio
-
Capital World Investors Los Angeles, CA2.55MShares$360 Million0.05% of portfolio
-
Lsv Asset Management Chicago, IL2.51MShares$354 Million0.73% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.84B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...